Similar articles

• Quetiapine and cataracts.

  Laties AM. Laties AM. Am J Psychiatry. 2002 Feb;159(2):322-3. doi: 10.1176/appi.ajp.159.2.322-b. Am J Psychiatry. 2002. PMID: 11823292 No abstract available.
• Antiaggressive action of combined risperidone and quetiapine in a patient with schizophrenia.

  Bozikas VP, Deseri C, Pitsavas S, Karavatos A. Bozikas VP, et al. Can J Psychiatry. 2003 Jul;48(6):426-7. doi: 10.1177/070674370304800617. Can J Psychiatry. 2003. PMID: 12894620 No abstract available.
• Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: a randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial.

  Laties AM, Flach AJ, Baldycheva I, Rak I, Earley W, Pathak S. Laties AM, et al. J Psychopharmacol. 2015 Jan;29(1):69-79. doi: 10.1177/0269881114553253. Epub 2014 Oct 14. J Psychopharmacol. 2015. PMID: 25315830 Clinical Trial.
• Quetiapine: a well-tolerated and effective atypical antipsychotic.

  Hellewell JS. Hellewell JS. Hosp Med. 2002 Oct;63(10):600-3. doi: 10.12968/hosp.2002.63.10.1931. Hosp Med. 2002. PMID: 12422494 Review.
• Quetiapine: efficacy and tolerability in schizophrenia.

  Kasper S, Tauscher J, Heiden A. Kasper S, et al. Eur Neuropsychopharmacol. 2001 Oct;11 Suppl 4:S405-13. doi: 10.1016/s0924-977x(01)00111-0. Eur Neuropsychopharmacol. 2001. PMID: 11587888 Review.